Clinical factors | Acute Phase | Delayed Phase | |||||
---|---|---|---|---|---|---|---|
OR | 95% CI | P value | OR | 95% CI | P value | ||
Group | 0.649 | 0.189-2.231 | 0.493 | 0.14 | 0.015-1.337 | 0.088 | |
Gender | 0.661 | 0.191-2.292 | 0.514 | 0.123 | 0.0040-4.002 | 0.238 | |
HTR3A | rs1062613 CC vs. Non-CC | 1.06 | 0.019-58.503 | 0.977 | |||
rs1176719 GG vs. Non-GG | 1.355 | 0.156-11.800 | 0.783 | 0.076 | 0.001-9.345 | 0.293 | |
rs2276303 GG vs. Non-GG | 0.294 | 0.027-3.193 | 0.315 | ||||
HTR3B | rs45460698 -100_-102AAG deletion variants vs. wild type | 1.297 | 0.092-18.193 | 0.847 | |||
rs7943062 GG vs. Non-GG | 0.004 | 0.000-0.221 | 0.007 | ||||
HTR3C | rs6766410 CC vs. Non-CC | 41645.423 | 19.065-90971913.963 | 0.007 | |||
ERCC1 | rs3212986 CC vs. Non-CC | 22.888 | 0.575-910.550 | 0.096 | |||
ERCC4 | rs744154 CC vs. Non-CC | 19,150,000,000 | 0.000-. | 1 | |||
MTHFR | rs1801131 TT vs. Non-TT | 0.263 | 0.074-0.926 | 0.038 | 0.005 | 0.000-0.807 | 0.041 |